HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qing Liu Selected Research

type v Syndactyly

2/2007Mutations in HOXD13 underlie syndactyly type V and a novel brachydactyly-syndactyly syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qing Liu Research Topics

Disease

286Neoplasms (Cancer)
11/2022 - 12/2004
57Neoplasm Metastasis (Metastasis)
11/2022 - 11/2006
54Inflammation (Inflammations)
06/2022 - 06/2011
52Infections
06/2022 - 01/2001
50Glioma (Gliomas)
10/2022 - 11/2008
45Nasopharyngeal Carcinoma
10/2022 - 11/2006
35Breast Neoplasms (Breast Cancer)
01/2022 - 09/2007
32Glioblastoma (Glioblastoma Multiforme)
10/2022 - 04/2014
29Esophageal Squamous Cell Carcinoma
03/2022 - 11/2009
28Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 12/2007
24Hepatocellular Carcinoma (Hepatoma)
04/2022 - 07/2004
24Carcinogenesis
04/2022 - 11/2009
24Carcinoma (Carcinomatosis)
09/2021 - 06/2006
22Body Weight (Weight, Body)
10/2021 - 08/2008
20Hypoxia (Hypoxemia)
05/2022 - 03/2004
20Obesity
01/2022 - 09/2010
20Stomach Neoplasms (Stomach Cancer)
01/2022 - 11/2007
20Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 08/2009
16Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 08/2011
16Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 06/2002
16Pain (Aches)
03/2021 - 10/2011
15Wounds and Injuries (Trauma)
08/2022 - 08/2007
15Lung Neoplasms (Lung Cancer)
06/2022 - 10/2007
15Fibrosis (Cirrhosis)
12/2021 - 05/2004
15Lymphatic Metastasis
05/2021 - 06/2010
14Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2007
14Cognitive Dysfunction
01/2022 - 01/2016
13Disease Progression
01/2022 - 11/2009
13Asthma (Bronchial Asthma)
04/2021 - 05/2003
12Neuroinflammatory Diseases
06/2022 - 01/2018
12Melanoma (Melanoma, Malignant)
06/2022 - 04/2013
12Reperfusion Injury
01/2022 - 06/2011
12Insulin Resistance
10/2021 - 08/2008
12Esophageal Neoplasms (Esophageal Cancer)
08/2021 - 06/2010
12Ischemia
06/2020 - 03/2007
11Sepsis (Septicemia)
01/2022 - 08/2008
11Necrosis
10/2021 - 08/2009
10Alzheimer Disease (Alzheimer's Disease)
11/2022 - 01/2013
10Lymphoma (Lymphomas)
01/2022 - 01/2008
10Atherosclerosis
01/2022 - 01/2015
10Myocardial Infarction
09/2021 - 03/2009
9Hyperplasia
01/2022 - 11/2013
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2015
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 06/2011
8Liver Neoplasms (Liver Cancer)
01/2022 - 03/2005
8Acute Kidney Injury (Acute Renal Failure)
01/2022 - 07/2011
8Hypertension (High Blood Pressure)
03/2021 - 07/2011
8Infarction (Infarctions)
01/2021 - 03/2009
8Liver Cirrhosis (Hepatic Cirrhosis)
11/2019 - 01/2015
7Pneumonia (Pneumonitis)
05/2022 - 09/2013

Drug/Important Bio-Agent (IBA)

109Proteins (Proteins, Gene)FDA Link
06/2022 - 03/2004
59Biomarkers (Surrogate Marker)IBA
06/2022 - 05/2003
46Pharmaceutical PreparationsIBA
02/2022 - 01/2007
44Messenger RNA (mRNA)IBA
01/2022 - 12/2004
41MicroRNAs (MicroRNA)IBA
02/2022 - 02/2012
37Biological ProductsIBA
06/2022 - 08/2008
35DNA (Deoxyribonucleic Acid)IBA
11/2022 - 02/2007
32Long Noncoding RNAIBA
06/2022 - 08/2016
31CytokinesIBA
10/2021 - 05/2004
27VaccinesIBA
01/2022 - 04/2014
24AntigensIBA
06/2022 - 05/2003
21LipidsIBA
02/2022 - 06/2006
20RNA (Ribonucleic Acid)IBA
10/2022 - 04/2004
19Small Interfering RNA (siRNA)IBA
04/2022 - 05/2009
19Interleukin-6 (Interleukin 6)IBA
08/2021 - 01/2001
17EnzymesIBA
11/2022 - 01/2001
17AntibodiesIBA
01/2022 - 01/2005
17AntioxidantsIBA
11/2021 - 01/2005
17Glucose (Dextrose)FDA LinkGeneric
05/2020 - 01/2007
16Therapeutic UsesIBA
01/2022 - 03/2010
15Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 05/2004
14Transcription Factors (Transcription Factor)IBA
09/2021 - 03/2004
14Hormones (Hormone)IBA
07/2021 - 01/2007
14C-Reactive ProteinIBA
01/2021 - 05/2009
13Cisplatin (Platino)FDA LinkGeneric
10/2022 - 06/2014
12Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2011
12Temozolomide (Temodar)FDA LinkGeneric
12/2021 - 02/2013
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 04/2009
11Circular RNAIBA
05/2022 - 01/2019
11Phosphotransferases (Kinase)IBA
01/2022 - 07/2006
10CateninsIBA
11/2021 - 05/2013
10Indicators and Reagents (Reagents)IBA
02/2020 - 04/2010
9Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 06/2006
9ChemokinesIBA
01/2021 - 08/2007
9Insulin (Novolin)FDA Link
01/2020 - 08/2008
8Leucine (L-Leucine)FDA Link
05/2022 - 10/2012
8Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 02/2013
8Pyruvate KinaseIBA
03/2022 - 02/2016
8Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 06/2004
8Immune Checkpoint InhibitorsIBA
01/2022 - 11/2018
8LipopolysaccharidesIBA
01/2021 - 12/2009

Therapy/Procedure

126Therapeutics
06/2022 - 01/2007
54Drug Therapy (Chemotherapy)
05/2022 - 06/2011
29Radiotherapy
03/2022 - 11/2006
19Chemoradiotherapy
10/2022 - 10/2010
18Immunotherapy
10/2022 - 06/2014
15Aftercare (After-Treatment)
01/2022 - 05/2004
13Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 03/2005
11Neoadjuvant Therapy
01/2022 - 09/2015
8Hysterectomy
01/2022 - 08/2011